Athersys Announces Positive Results From Its Exploratory Clinical Study of MultiStem® Cell Therapy for Treatment of Acute Respiratory Distress Syndrome (ARDS)

Stock Information for Athersys Inc.

Loading

Please wait while we load your information from QuoteMedia.